Glucagonoma Syndrome - 25 Studies Found
Terminated |
: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer :
|
Completed |
: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu :
|
Completed |
: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma :
|
Completed |
: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer :
|
Recruiting |
: Laser Tissue Welding - Distal Pancreatectomy Sealing Study :
|
Not yet recruiting |
: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor :
|
Completed |
: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors :
: 2001-06-06 : Drug: bortezomib |
Terminated |
: Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy : Pancreatic Cancer : 2010-01-25 :
|
Completed |
: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors :
: 2008-01-25 :
|
Completed |
: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors :
|